#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=Efficiently mitigating human exposure to air pollution is a top public health objective .
2-1	16-27	Efficiently	_	_	_	_
2-2	28-38	mitigating	_	_	_	_
2-3	39-44	human	abstract[2]	new[2]	coref	3-13[10_2]
2-4	45-53	exposure	abstract[2]	new[2]	_	_
2-5	54-56	to	abstract[2]	new[2]	_	_
2-6	57-60	air	abstract[2]|abstract[3]	new[2]|new[3]	coref	3-15[11_3]
2-7	61-70	pollution	abstract[2]|abstract[3]	new[2]|new[3]	_	_
2-8	71-73	is	_	_	_	_
2-9	74-75	a	abstract[5]	new[5]	_	_
2-10	76-79	top	abstract[5]	new[5]	_	_
2-11	80-86	public	abstract[4]|abstract[5]	new[4]|new[5]	coref	4-34[0_4]
2-12	87-93	health	abstract[4]|abstract[5]	new[4]|new[5]	_	_
2-13	94-103	objective	abstract[5]	new[5]	_	_
2-14	104-105	.	_	_	_	_

#Text=According to the most recent global burden of disease/comparative risk assessment , exposure to air pollution causes over 6.8 million premature deaths per year , with roughly equal contributions from ambient and household air pollution .
3-1	106-115	According	_	_	_	_
3-2	116-118	to	_	_	_	_
3-3	119-122	the	abstract[6]|abstract[9]	new[6]|new[9]	coref	6-6[42_9]
3-4	123-127	most	abstract[6]|abstract[9]	new[6]|new[9]	_	_
3-5	128-134	recent	abstract[6]|abstract[9]	new[6]|new[9]	_	_
3-6	135-141	global	abstract[6]|abstract[9]	new[6]|new[9]	_	_
3-7	142-148	burden	abstract[6]|abstract[9]	new[6]|new[9]	_	_
3-8	149-151	of	abstract[6]|abstract[9]	new[6]|new[9]	_	_
3-9	152-171	disease/comparative	abstract[6]|abstract|abstract[9]	new[6]|new|new[9]	_	_
3-10	172-176	risk	abstract|abstract[9]	new|new[9]	coref	17-25[137_0]
3-11	177-187	assessment	abstract[9]	new[9]	_	_
3-12	188-189	,	_	_	_	_
3-13	190-198	exposure	abstract[10]	giv[10]	coref	4-31[27_10]
3-14	199-201	to	abstract[10]	giv[10]	_	_
3-15	202-205	air	abstract[10]|abstract[11]	giv[10]|giv[11]	coref	3-31[16_11]
3-16	206-215	pollution	abstract[10]|abstract[11]	giv[10]|giv[11]	_	_
3-17	216-222	causes	_	_	_	_
3-18	223-227	over	event[12]	new[12]	_	_
3-19	228-231	6.8	event[12]	new[12]	_	_
3-20	232-239	million	event[12]	new[12]	_	_
3-21	240-249	premature	event[12]	new[12]	_	_
3-22	250-256	deaths	event[12]	new[12]	_	_
3-23	257-260	per	_	_	_	_
3-24	261-265	year	time	new	_	_
3-25	266-267	,	_	_	_	_
3-26	268-272	with	_	_	_	_
3-27	273-280	roughly	abstract[14]	new[14]	coref	11-16[84_14]
3-28	281-286	equal	abstract[14]	new[14]	_	_
3-29	287-300	contributions	abstract[14]	new[14]	_	_
3-30	301-305	from	abstract[14]	new[14]	_	_
3-31	306-313	ambient	abstract[14]|abstract[16]	new[14]|giv[16]	coref	4-10[19_16]
3-32	314-317	and	abstract[14]|abstract[16]	new[14]|giv[16]	_	_
3-33	318-327	household	abstract[14]|abstract[16]	new[14]|giv[16]	_	_
3-34	328-331	air	abstract[14]|substance|abstract[16]	new[14]|new|giv[16]	_	_
3-35	332-341	pollution	abstract[14]|abstract[16]	new[14]|giv[16]	_	_
3-36	342-343	.	_	_	_	_

#Text=While many countries acknowledge this danger and have enacted air pollution prevention laws , developing specific rules and regulations to implement these laws can be challenging when the relationships between pollutant exposure and health effects are underspecified .
4-1	344-349	While	_	_	_	_
4-2	350-354	many	place[17]	new[17]	_	_
4-3	355-364	countries	place[17]	new[17]	_	_
4-4	365-376	acknowledge	_	_	_	_
4-5	377-381	this	abstract[18]	new[18]	_	_
4-6	382-388	danger	abstract[18]	new[18]	_	_
4-7	389-392	and	_	_	_	_
4-8	393-397	have	_	_	_	_
4-9	398-405	enacted	_	_	_	_
4-10	406-409	air	abstract[19]|abstract[20]|abstract[21]	giv[19]|new[20]|new[21]	coref|coref	4-22[24_21]|6-2[39_19]
4-11	410-419	pollution	abstract[19]|abstract[20]|abstract[21]	giv[19]|new[20]|new[21]	_	_
4-12	420-430	prevention	abstract[20]|abstract[21]	new[20]|new[21]	_	_
4-13	431-435	laws	abstract[21]	new[21]	_	_
4-14	436-437	,	_	_	_	_
4-15	438-448	developing	_	_	_	_
4-16	449-457	specific	abstract[22]	new[22]	_	_
4-17	458-463	rules	abstract[22]	new[22]	_	_
4-18	464-467	and	_	_	_	_
4-19	468-479	regulations	abstract[23]	new[23]	_	_
4-20	480-482	to	abstract[23]	new[23]	_	_
4-21	483-492	implement	abstract[23]	new[23]	_	_
4-22	493-498	these	abstract[23]|abstract[24]	new[23]|giv[24]	_	_
4-23	499-503	laws	abstract[23]|abstract[24]	new[23]|giv[24]	_	_
4-24	504-507	can	_	_	_	_
4-25	508-510	be	_	_	_	_
4-26	511-522	challenging	_	_	_	_
4-27	523-527	when	_	_	_	_
4-28	528-531	the	abstract[25]	new[25]	coref	5-4[34_25]
4-29	532-545	relationships	abstract[25]	new[25]	_	_
4-30	546-553	between	abstract[25]	new[25]	_	_
4-31	554-563	pollutant	abstract[25]|substance|abstract[27]|abstract[28]	new[25]|new|giv[27]|new[28]	coref|coref|coref	5-4[0_27]|6-17[47_28]|12-8[89_0]
4-32	564-572	exposure	abstract[25]|abstract[27]|abstract[28]	new[25]|giv[27]|new[28]	_	_
4-33	573-576	and	abstract[25]|abstract[28]	new[25]|new[28]	_	_
4-34	577-583	health	abstract[25]|abstract[28]|abstract|abstract[30]	new[25]|new[28]|giv|new[30]	coref|coref	5-29[38_0]|6-24[50_30]
4-35	584-591	effects	abstract[25]|abstract[28]|abstract[30]	new[25]|new[28]|new[30]	_	_
4-36	592-595	are	_	_	_	_
4-37	596-610	underspecified	_	_	_	_
4-38	611-612	.	_	_	_	_

#Text=Better information on exposure response relationships ( how clean is clean enough ? ) can help regulators more effectively balance the often competing objectives of economic growth and public health .
5-1	613-619	Better	abstract[31]	new[31]	coref	19-1[149_31]
5-2	620-631	information	abstract[31]	new[31]	_	_
5-3	632-634	on	abstract[31]	new[31]	_	_
5-4	635-643	exposure	abstract[31]|abstract|abstract[34]	new[31]|giv|giv[34]	coref|coref	6-6|7-18[57_34]
5-5	644-652	response	abstract[31]|abstract|abstract[34]	new[31]|new|giv[34]	coref	16-29[128_0]
5-6	653-666	relationships	abstract[31]|abstract[34]	new[31]|giv[34]	_	_
5-7	667-668	(	_	_	_	_
5-8	669-672	how	_	_	_	_
5-9	673-678	clean	_	_	_	_
5-10	679-681	is	_	_	_	_
5-11	682-687	clean	_	_	_	_
5-12	688-694	enough	_	_	_	_
5-13	695-696	?	_	_	_	_
5-14	697-698	)	_	_	_	_
5-15	699-702	can	_	_	_	_
5-16	703-707	help	_	_	_	_
5-17	708-718	regulators	organization	new	_	_
5-18	719-723	more	_	_	_	_
5-19	724-735	effectively	_	_	_	_
5-20	736-743	balance	_	_	_	_
5-21	744-747	the	abstract[36]	new[36]	_	_
5-22	748-753	often	abstract[36]	new[36]	_	_
5-23	754-763	competing	abstract[36]	new[36]	_	_
5-24	764-774	objectives	abstract[36]	new[36]	_	_
5-25	775-777	of	abstract[36]	new[36]	_	_
5-26	778-786	economic	abstract[36]|abstract[37]	new[36]|new[37]	_	_
5-27	787-793	growth	abstract[36]|abstract[37]	new[36]|new[37]	_	_
5-28	794-797	and	abstract[36]	new[36]	_	_
5-29	798-804	public	abstract[36]|abstract[38]	new[36]|giv[38]	coref	6-25[0_38]
5-30	805-811	health	abstract[36]|abstract[38]	new[36]|giv[38]	_	_
5-31	812-813	.	_	_	_	_

#Text=In air pollution epidemiology , exposure assessment studies are the primary means for understanding links between exposure to chemical and physical agents and adverse health effects .
6-1	814-816	In	_	_	_	_
6-2	817-820	air	abstract[39]|abstract[40]	giv[39]|new[40]	coref	14-6[101_39]
6-3	821-830	pollution	abstract[39]|abstract[40]	giv[39]|new[40]	_	_
6-4	831-843	epidemiology	abstract[40]	new[40]	_	_
6-5	844-845	,	_	_	_	_
6-6	846-854	exposure	abstract|abstract[42]|abstract[43]	giv|giv[42]|new[43]	coref|coref|coref	6-10[44_43]|6-17[46_0]|7-3[52_42]
6-7	855-865	assessment	abstract[42]|abstract[43]	giv[42]|new[43]	_	_
6-8	866-873	studies	abstract[43]	new[43]	_	_
6-9	874-877	are	_	_	_	_
6-10	878-881	the	abstract[44]	giv[44]	coref	7-3[53_44]
6-11	882-889	primary	abstract[44]	giv[44]	_	_
6-12	890-895	means	abstract[44]	giv[44]	_	_
6-13	896-899	for	abstract[44]	giv[44]	_	_
6-14	900-913	understanding	abstract[44]	giv[44]	_	_
6-15	914-919	links	abstract[44]|abstract[45]	giv[44]|new[45]	_	_
6-16	920-927	between	abstract[44]|abstract[45]	giv[44]|new[45]	_	_
6-17	928-936	exposure	abstract[44]|abstract[45]|abstract[46]|abstract[47]	giv[44]|new[45]|giv[46]|giv[47]	coref	7-3[0_46]
6-18	937-939	to	abstract[44]|abstract[45]|abstract[46]|abstract[47]	giv[44]|new[45]|giv[46]|giv[47]	_	_
6-19	940-948	chemical	abstract[44]|abstract[45]|abstract[46]|abstract[47]|substance[48]	giv[44]|new[45]|giv[46]|giv[47]|new[48]	_	_
6-20	949-952	and	abstract[44]|abstract[45]|abstract[46]|abstract[47]|substance[48]	giv[44]|new[45]|giv[46]|giv[47]|new[48]	_	_
6-21	953-961	physical	abstract[44]|abstract[45]|abstract[46]|abstract[47]|substance[48]	giv[44]|new[45]|giv[46]|giv[47]|new[48]	_	_
6-22	962-968	agents	abstract[44]|abstract[45]|abstract[46]|abstract[47]|substance[48]	giv[44]|new[45]|giv[46]|giv[47]|new[48]	_	_
6-23	969-972	and	abstract[44]|abstract[45]|abstract[47]	giv[44]|new[45]|giv[47]	_	_
6-24	973-980	adverse	abstract[44]|abstract[45]|abstract[47]|abstract[50]	giv[44]|new[45]|giv[47]|giv[50]	_	_
6-25	981-987	health	abstract[44]|abstract[45]|abstract[47]|abstract|abstract[50]	giv[44]|new[45]|giv[47]|giv|giv[50]	coref	10-18
6-26	988-995	effects	abstract[44]|abstract[45]|abstract[47]|abstract[50]	giv[44]|new[45]|giv[47]|giv[50]	_	_
6-27	996-997	.	_	_	_	_

#Text=However , exposure assessment studies have traditionally used imperfect proxies based on central site data to assess these relationships , even though ambient concentrations are poor predictors of personal exposure .
7-1	998-1005	However	_	_	_	_
7-2	1006-1007	,	_	_	_	_
7-3	1008-1016	exposure	abstract|abstract[52]|abstract[53]	giv|giv[52]|giv[53]	coref|coref|coref	7-29[60_0]|14-9[0_52]|14-6[104_53]
7-4	1017-1027	assessment	abstract[52]|abstract[53]	giv[52]|giv[53]	_	_
7-5	1028-1035	studies	abstract[53]	giv[53]	_	_
7-6	1036-1040	have	_	_	_	_
7-7	1041-1054	traditionally	_	_	_	_
7-8	1055-1059	used	_	_	_	_
7-9	1060-1069	imperfect	abstract[54]	new[54]	_	_
7-10	1070-1077	proxies	abstract[54]	new[54]	_	_
7-11	1078-1083	based	abstract[54]	new[54]	_	_
7-12	1084-1086	on	abstract[54]	new[54]	_	_
7-13	1087-1094	central	abstract[54]|abstract[56]	new[54]|new[56]	coref	14-13[106_56]
7-14	1095-1099	site	abstract[54]|place|abstract[56]	new[54]|new|new[56]	_	_
7-15	1100-1104	data	abstract[54]|abstract[56]	new[54]|new[56]	_	_
7-16	1105-1107	to	_	_	_	_
7-17	1108-1114	assess	_	_	_	_
7-18	1115-1120	these	abstract[57]	giv[57]	_	_
7-19	1121-1134	relationships	abstract[57]	giv[57]	_	_
7-20	1135-1136	,	_	_	_	_
7-21	1137-1141	even	_	_	_	_
7-22	1142-1148	though	_	_	_	_
7-23	1149-1156	ambient	abstract[58]	new[58]	coref	7-26[59_58]
7-24	1157-1171	concentrations	abstract[58]	new[58]	_	_
7-25	1172-1175	are	_	_	_	_
7-26	1176-1180	poor	abstract[59]	giv[59]	coref	9-18[0_59]
7-27	1181-1191	predictors	abstract[59]	giv[59]	_	_
7-28	1192-1194	of	abstract[59]	giv[59]	_	_
7-29	1195-1203	personal	abstract[59]|abstract[60]	giv[59]|giv[60]	coref	8-3[61_60]
7-30	1204-1212	exposure	abstract[59]|abstract[60]	giv[59]|giv[60]	_	_
7-31	1213-1214	.	_	_	_	_

#Text=For measuring personal exposure , ambient concentration readings from stationary sensors have many drawbacks .
8-1	1215-1218	For	_	_	_	_
8-2	1219-1228	measuring	_	_	_	_
8-3	1229-1237	personal	abstract[61]	giv[61]	coref	11-23[87_61]
8-4	1238-1246	exposure	abstract[61]	giv[61]	_	_
8-5	1247-1248	,	_	_	_	_
8-6	1249-1256	ambient	abstract[63]	new[63]	_	_
8-7	1257-1270	concentration	abstract|abstract[63]	new|new[63]	coref	20-34[171_0]
8-8	1271-1279	readings	abstract[63]	new[63]	_	_
8-9	1280-1284	from	abstract[63]	new[63]	_	_
8-10	1285-1295	stationary	abstract[63]|object[64]	new[63]|new[64]	coref	10-1[74_64]
8-11	1296-1303	sensors	abstract[63]|object[64]	new[63]|new[64]	_	_
8-12	1304-1308	have	_	_	_	_
8-13	1309-1313	many	abstract[65]	new[65]	_	_
8-14	1314-1323	drawbacks	abstract[65]	new[65]	_	_
8-15	1324-1325	.	_	_	_	_

#Text=First , people move through multiple indoor and outdoor micro-environments with fine-scale spatial and temporal heterogeneity in concentrations , resulting in substantial person-to-person variation even among individuals living within the same building or neighborhood .
9-1	1326-1331	First	_	_	_	_
9-2	1332-1333	,	_	_	_	_
9-3	1334-1340	people	person	new	_	_
9-4	1341-1345	move	_	_	_	_
9-5	1346-1353	through	_	_	_	_
9-6	1354-1362	multiple	abstract[67]	new[67]	_	_
9-7	1363-1369	indoor	abstract[67]	new[67]	_	_
9-8	1370-1373	and	abstract[67]	new[67]	_	_
9-9	1374-1381	outdoor	abstract[67]	new[67]	_	_
9-10	1382-1400	micro-environments	abstract[67]	new[67]	_	_
9-11	1401-1405	with	abstract[67]	new[67]	_	_
9-12	1406-1416	fine-scale	abstract[67]|abstract[68]	new[67]|new[68]	coref	15-18[115_68]
9-13	1417-1424	spatial	abstract[67]|abstract[68]	new[67]|new[68]	_	_
9-14	1425-1428	and	abstract[67]|abstract[68]	new[67]|new[68]	_	_
9-15	1429-1437	temporal	abstract[67]|abstract[68]	new[67]|new[68]	_	_
9-16	1438-1451	heterogeneity	abstract[67]|abstract[68]	new[67]|new[68]	_	_
9-17	1452-1454	in	abstract[67]|abstract[68]	new[67]|new[68]	_	_
9-18	1455-1469	concentrations	abstract[67]|abstract[68]|abstract	new[67]|new[68]|giv	coref	16-34[130_0]
9-19	1470-1471	,	_	_	_	_
9-20	1472-1481	resulting	_	_	_	_
9-21	1482-1484	in	_	_	_	_
9-22	1485-1496	substantial	abstract[70]	new[70]	_	_
9-23	1497-1513	person-to-person	abstract[70]	new[70]	_	_
9-24	1514-1523	variation	abstract[70]	new[70]	_	_
9-25	1524-1528	even	abstract[70]|person[71]	new[70]|new[71]	_	_
9-26	1529-1534	among	abstract[70]|person[71]	new[70]|new[71]	_	_
9-27	1535-1546	individuals	abstract[70]|person[71]	new[70]|new[71]	_	_
9-28	1547-1553	living	abstract[70]|person[71]	new[70]|new[71]	_	_
9-29	1554-1560	within	abstract[70]|person[71]	new[70]|new[71]	_	_
9-30	1561-1564	the	abstract[70]|person[71]|place[72]	new[70]|new[71]|new[72]	_	_
9-31	1565-1569	same	abstract[70]|person[71]|place[72]	new[70]|new[71]|new[72]	_	_
9-32	1570-1578	building	abstract[70]|person[71]|place[72]	new[70]|new[71]|new[72]	_	_
9-33	1579-1581	or	abstract[70]|person[71]	new[70]|new[71]	_	_
9-34	1582-1594	neighborhood	abstract[70]|person[71]|place	new[70]|new[71]|new	_	_
9-35	1595-1596	.	_	_	_	_

#Text=Stationary sensors are unable to capture these differences in daily routines and resulting exposures , potentially biasing health effect estimates .
10-1	1597-1607	Stationary	object[74]	giv[74]	ana	11-6[0_74]
10-2	1608-1615	sensors	object[74]	giv[74]	_	_
10-3	1616-1619	are	_	_	_	_
10-4	1620-1626	unable	_	_	_	_
10-5	1627-1629	to	_	_	_	_
10-6	1630-1637	capture	_	_	_	_
10-7	1638-1643	these	abstract[75]	new[75]	_	_
10-8	1644-1655	differences	abstract[75]	new[75]	_	_
10-9	1656-1658	in	abstract[75]	new[75]	_	_
10-10	1659-1664	daily	abstract[75]|abstract[76]	new[75]|new[76]	_	_
10-11	1665-1673	routines	abstract[75]|abstract[76]	new[75]|new[76]	_	_
10-12	1674-1677	and	abstract[75]	new[75]	_	_
10-13	1678-1687	resulting	abstract[75]|abstract[77]	new[75]|new[77]	coref	14-30[110_77]
10-14	1688-1697	exposures	abstract[75]|abstract[77]	new[75]|new[77]	_	_
10-15	1698-1699	,	_	_	_	_
10-16	1700-1711	potentially	_	_	_	_
10-17	1712-1719	biasing	_	_	_	_
10-18	1720-1726	health	abstract|abstract[79]|abstract[80]	giv|new[79]|new[80]	coref|coref	13-8|13-15[99_80]
10-19	1727-1733	effect	abstract[79]|abstract[80]	new[79]|new[80]	_	_
10-20	1734-1743	estimates	abstract[80]	new[80]	_	_
10-21	1744-1745	.	_	_	_	_

#Text=In addition , due to their fixed nature , stationary sensors are unable to decouple the spatiotemporal contributions of individual sources to a person ’s exposure .
11-1	1746-1748	In	_	_	_	_
11-2	1749-1757	addition	_	_	_	_
11-3	1758-1759	,	_	_	_	_
11-4	1760-1763	due	_	_	_	_
11-5	1764-1766	to	_	_	_	_
11-6	1767-1772	their	object|abstract[82]	giv|new[82]	coref	11-10[83_0]
11-7	1773-1778	fixed	abstract[82]	new[82]	_	_
11-8	1779-1785	nature	abstract[82]	new[82]	_	_
11-9	1786-1787	,	_	_	_	_
11-10	1788-1798	stationary	object[83]	giv[83]	coref	15-2[111_83]
11-11	1799-1806	sensors	object[83]	giv[83]	_	_
11-12	1807-1810	are	_	_	_	_
11-13	1811-1817	unable	_	_	_	_
11-14	1818-1820	to	_	_	_	_
11-15	1821-1829	decouple	_	_	_	_
11-16	1830-1833	the	abstract[84]	giv[84]	_	_
11-17	1834-1848	spatiotemporal	abstract[84]	giv[84]	_	_
11-18	1849-1862	contributions	abstract[84]	giv[84]	_	_
11-19	1863-1865	of	abstract[84]	giv[84]	_	_
11-20	1866-1876	individual	abstract[84]|abstract[85]	giv[84]|new[85]	coref	23-38[198_85]
11-21	1877-1884	sources	abstract[84]|abstract[85]	giv[84]|new[85]	_	_
11-22	1885-1887	to	_	_	_	_
11-23	1888-1889	a	abstract[87]	giv[87]	coref	14-8[0_87]
11-24	1890-1896	person	person[86]|abstract[87]	new[86]|giv[87]	_	_
11-25	1897-1899	’s	person[86]|abstract[87]	new[86]|giv[87]	_	_
11-26	1900-1908	exposure	abstract[87]	giv[87]	_	_
11-27	1909-1910	.	_	_	_	_

#Text=Finally , the actual inhaled dose of a pollutant is a function of respiration rate , and , thus , of physical activity patterns .
12-1	1911-1918	Finally	_	_	_	_
12-2	1919-1920	,	_	_	_	_
12-3	1921-1924	the	abstract[88]	new[88]	coref	12-11[90_88]
12-4	1925-1931	actual	abstract[88]	new[88]	_	_
12-5	1932-1939	inhaled	abstract[88]	new[88]	_	_
12-6	1940-1944	dose	abstract[88]	new[88]	_	_
12-7	1945-1947	of	abstract[88]	new[88]	_	_
12-8	1948-1949	a	abstract[88]|substance[89]	new[88]|giv[89]	coref	14-31[0_89]
12-9	1950-1959	pollutant	abstract[88]|substance[89]	new[88]|giv[89]	_	_
12-10	1960-1962	is	_	_	_	_
12-11	1963-1964	a	abstract[90]	giv[90]	_	_
12-12	1965-1973	function	abstract[90]	giv[90]	_	_
12-13	1974-1976	of	abstract[90]	giv[90]	_	_
12-14	1977-1988	respiration	abstract[90]|abstract|abstract[92]	giv[90]|new|new[92]	coref	16-10
12-15	1989-1993	rate	abstract[90]|abstract[92]	giv[90]|new[92]	_	_
12-16	1994-1995	,	abstract[90]	giv[90]	_	_
12-17	1996-1999	and	abstract[90]	giv[90]	_	_
12-18	2000-2001	,	abstract[90]	giv[90]	_	_
12-19	2002-2006	thus	abstract[90]	giv[90]	_	_
12-20	2007-2008	,	abstract[90]	giv[90]	_	_
12-21	2009-2011	of	abstract[90]	giv[90]	_	_
12-22	2012-2020	physical	abstract[90]|event[93]|abstract[94]	giv[90]|new[93]|new[94]	coref|coref	13-2[95_93]|29-20[263_94]
12-23	2021-2029	activity	abstract[90]|event[93]|abstract[94]	giv[90]|new[93]|new[94]	_	_
12-24	2030-2038	patterns	abstract[90]|abstract[94]	giv[90]|new[94]	_	_
12-25	2039-2040	.	_	_	_	_

#Text=Since physical activity protects against many pollution-sensitive health outcomes , this may again confound average concentration-based estimates .
13-1	2041-2046	Since	_	_	_	_
13-2	2047-2055	physical	event[95]	giv[95]	ana	13-11[0_95]
13-3	2056-2064	activity	event[95]	giv[95]	_	_
13-4	2065-2073	protects	_	_	_	_
13-5	2074-2081	against	_	_	_	_
13-6	2082-2086	many	abstract[97]	new[97]	coref	30-13[271_97]
13-7	2087-2106	pollution-sensitive	abstract[97]	new[97]	_	_
13-8	2107-2113	health	abstract|abstract[97]	giv|new[97]	coref	28-30
13-9	2114-2122	outcomes	abstract[97]	new[97]	_	_
13-10	2123-2124	,	_	_	_	_
13-11	2125-2129	this	event	giv	coref	18-14[145_0]
13-12	2130-2133	may	_	_	_	_
13-13	2134-2139	again	_	_	_	_
13-14	2140-2148	confound	_	_	_	_
13-15	2149-2156	average	abstract[99]	giv[99]	_	_
13-16	2157-2176	concentration-based	abstract[99]	giv[99]	_	_
13-17	2177-2186	estimates	abstract[99]	giv[99]	_	_
13-18	2187-2188	.	_	_	_	_

#Text=To help address concerns with air pollution exposure assessment studies based on fixed , centrally located sensor data , researchers have proposed using wearable monitors to more accurately capture personalized pollutant exposures .
14-1	2189-2191	To	_	_	_	_
14-2	2192-2196	help	_	_	_	_
14-3	2197-2204	address	_	_	_	_
14-4	2205-2213	concerns	abstract[100]	new[100]	_	_
14-5	2214-2218	with	abstract[100]	new[100]	_	_
14-6	2219-2222	air	abstract[100]|abstract[101]|abstract[104]	new[100]|giv[101]|giv[104]	coref	27-7[228_104]
14-7	2223-2232	pollution	abstract[100]|abstract[101]|abstract[104]	new[100]|giv[101]|giv[104]	_	_
14-8	2233-2241	exposure	abstract[100]|abstract|abstract[104]	new[100]|giv|giv[104]	coref	16-5
14-9	2242-2252	assessment	abstract[100]|abstract|abstract[104]	new[100]|giv|giv[104]	coref	28-30[252_0]
14-10	2253-2260	studies	abstract[100]|abstract[104]	new[100]|giv[104]	_	_
14-11	2261-2266	based	abstract[100]|abstract[104]	new[100]|giv[104]	_	_
14-12	2267-2269	on	abstract[100]|abstract[104]	new[100]|giv[104]	_	_
14-13	2270-2275	fixed	abstract[100]|abstract[104]|abstract[106]	new[100]|giv[104]|giv[106]	coref	16-4[120_106]
14-14	2276-2277	,	abstract[100]|abstract[104]|abstract[106]	new[100]|giv[104]|giv[106]	_	_
14-15	2278-2287	centrally	abstract[100]|abstract[104]|abstract[106]	new[100]|giv[104]|giv[106]	_	_
14-16	2288-2295	located	abstract[100]|abstract[104]|abstract[106]	new[100]|giv[104]|giv[106]	_	_
14-17	2296-2302	sensor	abstract[100]|abstract[104]|person|abstract[106]	new[100]|giv[104]|new|giv[106]	_	_
14-18	2303-2307	data	abstract[100]|abstract[104]|abstract[106]	new[100]|giv[104]|giv[106]	_	_
14-19	2308-2309	,	_	_	_	_
14-20	2310-2321	researchers	person	new	_	_
14-21	2322-2326	have	_	_	_	_
14-22	2327-2335	proposed	_	_	_	_
14-23	2336-2341	using	_	_	_	_
14-24	2342-2350	wearable	object[108]	new[108]	coref	15-5[112_108]
14-25	2351-2359	monitors	object[108]	new[108]	_	_
14-26	2360-2362	to	_	_	_	_
14-27	2363-2367	more	_	_	_	_
14-28	2368-2378	accurately	_	_	_	_
14-29	2379-2386	capture	_	_	_	_
14-30	2387-2399	personalized	abstract[110]	giv[110]	coref	15-10[113_110]
14-31	2400-2409	pollutant	substance|abstract[110]	giv|giv[110]	_	_
14-32	2410-2419	exposures	abstract[110]	giv[110]	_	_
14-33	2420-2421	.	_	_	_	_

#Text=Unlike stationary sensors , personal monitors can better capture exposures actually experienced by the wearers and provides the spatial and temporal heterogeneity necessary to design interventions incorporating human behaviors and lifestyle .
15-1	2422-2428	Unlike	_	_	_	_
15-2	2429-2439	stationary	object[111]	giv[111]	_	_
15-3	2440-2447	sensors	object[111]	giv[111]	_	_
15-4	2448-2449	,	_	_	_	_
15-5	2450-2458	personal	object[112]	giv[112]	_	_
15-6	2459-2467	monitors	object[112]	giv[112]	_	_
15-7	2468-2471	can	_	_	_	_
15-8	2472-2478	better	_	_	_	_
15-9	2479-2486	capture	_	_	_	_
15-10	2487-2496	exposures	abstract[113]	giv[113]	coref	27-4[227_113]
15-11	2497-2505	actually	abstract[113]	giv[113]	_	_
15-12	2506-2517	experienced	abstract[113]	giv[113]	_	_
15-13	2518-2520	by	abstract[113]	giv[113]	_	_
15-14	2521-2524	the	abstract[113]|person[114]	giv[113]|new[114]	_	_
15-15	2525-2532	wearers	abstract[113]|person[114]	giv[113]|new[114]	_	_
15-16	2533-2536	and	_	_	_	_
15-17	2537-2545	provides	_	_	_	_
15-18	2546-2549	the	abstract[115]	giv[115]	_	_
15-19	2550-2557	spatial	abstract[115]	giv[115]	_	_
15-20	2558-2561	and	abstract[115]	giv[115]	_	_
15-21	2562-2570	temporal	abstract[115]	giv[115]	_	_
15-22	2571-2584	heterogeneity	abstract[115]	giv[115]	_	_
15-23	2585-2594	necessary	abstract[115]	giv[115]	_	_
15-24	2595-2597	to	abstract[115]	giv[115]	_	_
15-25	2598-2604	design	abstract[115]	giv[115]	_	_
15-26	2605-2618	interventions	abstract[115]|event[116]	giv[115]|new[116]	_	_
15-27	2619-2632	incorporating	abstract[115]|event[116]	giv[115]|new[116]	_	_
15-28	2633-2638	human	abstract[115]|event[116]|abstract[117]	giv[115]|new[116]|new[117]	_	_
15-29	2639-2648	behaviors	abstract[115]|event[116]|abstract[117]	giv[115]|new[116]|new[117]	_	_
15-30	2649-2652	and	abstract[115]|event[116]	giv[115]|new[116]	_	_
15-31	2653-2662	lifestyle	abstract[115]|event[116]|abstract	giv[115]|new[116]|new	ana	16-13
15-32	2663-2664	.	_	_	_	_

#Text=Furthermore , if personal exposure data is combined with respiration data , it becomes possible to estimate potential inhaled dose , a much higher fidelity measure for mapping the exposure response than using device concentrations alone .
16-1	2665-2676	Furthermore	_	_	_	_
16-2	2677-2678	,	_	_	_	_
16-3	2679-2681	if	_	_	_	_
16-4	2682-2690	personal	abstract[120]	giv[120]	coref	16-10[122_120]
16-5	2691-2699	exposure	abstract|abstract[120]	giv|giv[120]	coref	16-30
16-6	2700-2704	data	abstract[120]	giv[120]	_	_
16-7	2705-2707	is	_	_	_	_
16-8	2708-2716	combined	_	_	_	_
16-9	2717-2721	with	_	_	_	_
16-10	2722-2733	respiration	abstract|abstract[122]	giv|giv[122]	coref|coref	18-18[148_122]|23-32
16-11	2734-2738	data	abstract[122]	giv[122]	_	_
16-12	2739-2740	,	_	_	_	_
16-13	2741-2743	it	abstract	giv	_	_
16-14	2744-2751	becomes	_	_	_	_
16-15	2752-2760	possible	_	_	_	_
16-16	2761-2763	to	_	_	_	_
16-17	2764-2772	estimate	_	_	_	_
16-18	2773-2782	potential	abstract[124]	new[124]	appos	16-22[126_124]
16-19	2783-2790	inhaled	abstract[124]	new[124]	_	_
16-20	2791-2795	dose	abstract[124]	new[124]	_	_
16-21	2796-2797	,	_	_	_	_
16-22	2798-2799	a	abstract[126]	giv[126]	coref	19-14[152_126]
16-23	2800-2804	much	abstract[126]	giv[126]	_	_
16-24	2805-2811	higher	abstract[126]	giv[126]	_	_
16-25	2812-2820	fidelity	organization|abstract[126]	new|giv[126]	_	_
16-26	2821-2828	measure	abstract[126]	giv[126]	_	_
16-27	2829-2832	for	abstract[126]	giv[126]	_	_
16-28	2833-2840	mapping	abstract[126]	giv[126]	_	_
16-29	2841-2844	the	abstract[126]|abstract[128]	giv[126]|giv[128]	_	_
16-30	2845-2853	exposure	abstract[126]|abstract|abstract[128]	giv[126]|giv|giv[128]	coref	18-19
16-31	2854-2862	response	abstract[126]|abstract[128]	giv[126]|giv[128]	_	_
16-32	2863-2867	than	_	_	_	_
16-33	2868-2873	using	_	_	_	_
16-34	2874-2880	device	object|abstract[130]	new|giv[130]	coref|coref	19-19[154_0]|24-43[214_130]
16-35	2881-2895	concentrations	abstract[130]	giv[130]	_	_
16-36	2896-2901	alone	_	_	_	_
16-37	2902-2903	.	_	_	_	_

#Text=However , passively measuring respiratory rates is not always possible without subjects wearing additional devices , increasing the level of study complexity and increasing the risk of protocol non-compliance .
17-1	2904-2911	However	_	_	_	_
17-2	2912-2913	,	_	_	_	_
17-3	2914-2923	passively	_	_	_	_
17-4	2924-2933	measuring	_	_	_	_
17-5	2934-2945	respiratory	abstract[131]	new[131]	coref	19-10[151_131]
17-6	2946-2951	rates	abstract[131]	new[131]	_	_
17-7	2952-2954	is	_	_	_	_
17-8	2955-2958	not	_	_	_	_
17-9	2959-2965	always	_	_	_	_
17-10	2966-2974	possible	_	_	_	_
17-11	2975-2982	without	_	_	_	_
17-12	2983-2991	subjects	person	new	_	_
17-13	2992-2999	wearing	_	_	_	_
17-14	3000-3010	additional	object[133]	new[133]	_	_
17-15	3011-3018	devices	object[133]	new[133]	_	_
17-16	3019-3020	,	_	_	_	_
17-17	3021-3031	increasing	_	_	_	_
17-18	3032-3035	the	abstract[134]	new[134]	_	_
17-19	3036-3041	level	abstract[134]	new[134]	_	_
17-20	3042-3044	of	abstract[134]	new[134]	_	_
17-21	3045-3050	study	abstract[134]|abstract|abstract[136]	new[134]|new|new[136]	coref	18-2[140_0]
17-22	3051-3061	complexity	abstract[134]|abstract[136]	new[134]|new[136]	_	_
17-23	3062-3065	and	_	_	_	_
17-24	3066-3076	increasing	_	_	_	_
17-25	3077-3080	the	abstract[137]	giv[137]	_	_
17-26	3081-3085	risk	abstract[137]	giv[137]	_	_
17-27	3086-3088	of	abstract[137]	giv[137]	_	_
17-28	3089-3097	protocol	abstract[137]|abstract|abstract[139]	giv[137]|new|new[139]	_	_
17-29	3098-3112	non-compliance	abstract[137]|abstract[139]	giv[137]|new[139]	_	_
17-30	3113-3114	.	_	_	_	_

#Text=In this study , we focus on classification methods for determining levels of high activity directly from wearable exposure monitor data .
18-1	3115-3117	In	_	_	_	_
18-2	3118-3122	this	abstract[140]	giv[140]	coref	25-1[216_140]
18-3	3123-3128	study	abstract[140]	giv[140]	_	_
18-4	3129-3130	,	_	_	_	_
18-5	3131-3133	we	person	acc	ana	20-3
18-6	3134-3139	focus	abstract	new	coref|none	22-1[176_0]|18-6[0_176]
18-7	3140-3142	on	_	_	_	_
18-8	3143-3157	classification	abstract|abstract[143]	new|new[143]	_	_
18-9	3158-3165	methods	abstract[143]	new[143]	_	_
18-10	3166-3169	for	abstract[143]	new[143]	_	_
18-11	3170-3181	determining	abstract[143]	new[143]	_	_
18-12	3182-3188	levels	abstract[143]|abstract[144]	new[143]|new[144]	_	_
18-13	3189-3191	of	abstract[143]|abstract[144]	new[143]|new[144]	_	_
18-14	3192-3196	high	abstract[143]|abstract[144]|event[145]	new[143]|new[144]|giv[145]	coref	20-13[163_145]
18-15	3197-3205	activity	abstract[143]|abstract[144]|event[145]	new[143]|new[144]|giv[145]	_	_
18-16	3206-3214	directly	abstract[143]	new[143]	_	_
18-17	3215-3219	from	abstract[143]	new[143]	_	_
18-18	3220-3228	wearable	abstract[143]|abstract[148]	new[143]|giv[148]	coref	20-16[164_148]
18-19	3229-3237	exposure	abstract[143]|abstract|object[147]|abstract[148]	new[143]|giv|new[147]|giv[148]	coref|coref	19-26|20-20[168_147]
18-20	3238-3245	monitor	abstract[143]|object[147]|abstract[148]	new[143]|new[147]|giv[148]	_	_
18-21	3246-3250	data	abstract[143]|abstract[148]	new[143]|giv[148]	_	_
18-22	3251-3252	.	_	_	_	_

#Text=This information can be used to develop tiers of respiratory rates for potential inhaled dose calculations , using the same wearable device required for personal exposure monitoring .
19-1	3253-3257	This	abstract[149]	giv[149]	_	_
19-2	3258-3269	information	abstract[149]	giv[149]	_	_
19-3	3270-3273	can	_	_	_	_
19-4	3274-3276	be	_	_	_	_
19-5	3277-3281	used	_	_	_	_
19-6	3282-3284	to	_	_	_	_
19-7	3285-3292	develop	_	_	_	_
19-8	3293-3298	tiers	abstract[150]	new[150]	_	_
19-9	3299-3301	of	abstract[150]	new[150]	_	_
19-10	3302-3313	respiratory	abstract[150]|abstract[151]	new[150]|giv[151]	coref	23-30[193_151]
19-11	3314-3319	rates	abstract[150]|abstract[151]	new[150]|giv[151]	_	_
19-12	3320-3323	for	_	_	_	_
19-13	3324-3333	potential	abstract[153]	new[153]	_	_
19-14	3334-3341	inhaled	abstract[152]|abstract[153]	giv[152]|new[153]	coref	23-13[189_152]
19-15	3342-3346	dose	abstract[152]|abstract[153]	giv[152]|new[153]	_	_
19-16	3347-3359	calculations	abstract[153]	new[153]	_	_
19-17	3360-3361	,	_	_	_	_
19-18	3362-3367	using	_	_	_	_
19-19	3368-3371	the	object[154]	giv[154]	_	_
19-20	3372-3376	same	object[154]	giv[154]	_	_
19-21	3377-3385	wearable	object[154]	giv[154]	_	_
19-22	3386-3392	device	object[154]	giv[154]	_	_
19-23	3393-3401	required	object[154]	giv[154]	_	_
19-24	3402-3405	for	object[154]	giv[154]	_	_
19-25	3406-3414	personal	object[154]|abstract[156]	giv[154]|new[156]	_	_
19-26	3415-3423	exposure	object[154]|abstract|abstract[156]	giv[154]|giv|new[156]	coref	20-24
19-27	3424-3434	monitoring	object[154]|abstract[156]	giv[154]|new[156]	_	_
19-28	3435-3436	.	_	_	_	_

#Text=Specifically , we develop a machine learning model for identifying periods of bicycling activity using passively collected data from the RTI MicroPEM wearable exposure monitor , a lightweight device capable of continuously sampling both particulate matter concentration and the wearer ’s acceleration .
20-1	3437-3449	Specifically	_	_	_	_
20-2	3450-3451	,	_	_	_	_
20-3	3452-3454	we	person	giv	ana	22-1
20-4	3455-3462	develop	_	_	_	_
20-5	3463-3464	a	abstract[160]	new[160]	_	_
20-6	3465-3472	machine	object|abstract[159]|abstract[160]	new|new[159]|new[160]	_	_
20-7	3473-3481	learning	abstract[159]|abstract[160]	new[159]|new[160]	_	_
20-8	3482-3487	model	abstract[160]	new[160]	_	_
20-9	3488-3491	for	abstract[160]	new[160]	_	_
20-10	3492-3503	identifying	abstract[160]	new[160]	_	_
20-11	3504-3511	periods	abstract[160]|time[161]	new[160]|new[161]	coref	22-5[177_161]
20-12	3512-3514	of	abstract[160]|time[161]	new[160]|new[161]	_	_
20-13	3515-3524	bicycling	abstract[160]|time[161]|organization|event[163]	new[160]|new[161]|new|giv[163]	coref|coref	22-7|22-7[179_163]
20-14	3525-3533	activity	abstract[160]|time[161]|event[163]	new[160]|new[161]|giv[163]	_	_
20-15	3534-3539	using	_	_	_	_
20-16	3540-3549	passively	abstract[164]	giv[164]	_	_
20-17	3550-3559	collected	abstract[164]	giv[164]	_	_
20-18	3560-3564	data	abstract[164]	giv[164]	_	_
20-19	3565-3569	from	abstract[164]	giv[164]	_	_
20-20	3570-3573	the	abstract[164]|object[168]	giv[164]|giv[168]	appos	20-27[169_168]
20-21	3574-3577	RTI	abstract[164]|abstract|abstract[166]|object[168]	giv[164]|new|new[166]|giv[168]	_	_
20-22	3578-3586	MicroPEM	abstract[164]|abstract[166]|object[168]	giv[164]|new[166]|giv[168]	_	_
20-23	3587-3595	wearable	abstract[164]|object[168]	giv[164]|giv[168]	_	_
20-24	3596-3604	exposure	abstract[164]|abstract|object[168]	giv[164]|giv|giv[168]	coref	22-19[182_0]
20-25	3605-3612	monitor	abstract[164]|object[168]	giv[164]|giv[168]	_	_
20-26	3613-3614	,	_	_	_	_
20-27	3615-3616	a	object[169]	giv[169]	_	_
20-28	3617-3628	lightweight	object[169]	giv[169]	_	_
20-29	3629-3635	device	object[169]	giv[169]	_	_
20-30	3636-3643	capable	object[169]	giv[169]	_	_
20-31	3644-3646	of	_	_	_	_
20-32	3647-3659	continuously	_	_	_	_
20-33	3660-3668	sampling	_	_	_	_
20-34	3669-3673	both	abstract[171]	giv[171]	_	_
20-35	3674-3685	particulate	abstract[171]	giv[171]	_	_
20-36	3686-3692	matter	substance|abstract[171]	new|giv[171]	_	_
20-37	3693-3706	concentration	abstract[171]	giv[171]	_	_
20-38	3707-3710	and	_	_	_	_
20-39	3711-3714	the	abstract[173]	new[173]	_	_
20-40	3715-3721	wearer	person[172]|abstract[173]	new[172]|new[173]	_	_
20-41	3722-3724	’s	person[172]|abstract[173]	new[172]|new[173]	_	_
20-42	3725-3737	acceleration	abstract[173]	new[173]	_	_
20-43	3738-3739	.	_	_	_	_

#Text=1.1. Motivation
21-1	3740-3744	1.1.	_	_	_	_
21-2	3745-3755	Motivation	abstract	new	_	_

#Text=Our focus on identifying periods of bicycling activity is motivated by the elevated risk of urban cyclists for pollutant exposure when compared to other urban residents .
22-1	3756-3759	Our	person|abstract[176]	giv|new[176]	_	_
22-2	3760-3765	focus	abstract[176]	new[176]	_	_
22-3	3766-3768	on	abstract[176]	new[176]	_	_
22-4	3769-3780	identifying	abstract[176]	new[176]	_	_
22-5	3781-3788	periods	abstract[176]|time[177]	new[176]|giv[177]	_	_
22-6	3789-3791	of	abstract[176]|time[177]	new[176]|giv[177]	_	_
22-7	3792-3801	bicycling	abstract[176]|time[177]|organization|event[179]	new[176]|giv[177]|giv|giv[179]	coref	27-37
22-8	3802-3810	activity	abstract[176]|time[177]|event[179]	new[176]|giv[177]|giv[179]	_	_
22-9	3811-3813	is	_	_	_	_
22-10	3814-3823	motivated	_	_	_	_
22-11	3824-3826	by	_	_	_	_
22-12	3827-3830	the	abstract[180]	new[180]	_	_
22-13	3831-3839	elevated	abstract[180]	new[180]	_	_
22-14	3840-3844	risk	abstract[180]	new[180]	_	_
22-15	3845-3847	of	abstract[180]	new[180]	_	_
22-16	3848-3853	urban	abstract[180]|person[181]	new[180]|new[181]	coref	23-2[184_181]
22-17	3854-3862	cyclists	abstract[180]|person[181]	new[180]|new[181]	_	_
22-18	3863-3866	for	abstract[180]|person[181]	new[180]|new[181]	_	_
22-19	3867-3876	pollutant	abstract[180]|person[181]|abstract[182]	new[180]|new[181]|giv[182]	coref	28-28[0_182]
22-20	3877-3885	exposure	abstract[180]|person[181]|abstract[182]	new[180]|new[181]|giv[182]	_	_
22-21	3886-3890	when	_	_	_	_
22-22	3891-3899	compared	_	_	_	_
22-23	3900-3902	to	_	_	_	_
22-24	3903-3908	other	person[183]	new[183]	coref	23-22[190_183]
22-25	3909-3914	urban	person[183]	new[183]	_	_
22-26	3915-3924	residents	person[183]	new[183]	_	_
22-27	3925-3926	.	_	_	_	_

#Text=Since urban cyclists undertake strenuous exercise in close proximity to traffic , their potential dose is likely to be higher than many other urban residents , due both to their increased respiration rates and their proximity to traffic sources .
23-1	3927-3932	Since	_	_	_	_
23-2	3933-3938	urban	person[184]	giv[184]	ana	23-13[0_184]
23-3	3939-3947	cyclists	person[184]	giv[184]	_	_
23-4	3948-3957	undertake	_	_	_	_
23-5	3958-3967	strenuous	event[185]	new[185]	coref	31-4[0_185]
23-6	3968-3976	exercise	event[185]	new[185]	_	_
23-7	3977-3979	in	_	_	_	_
23-8	3980-3985	close	place[186]	new[186]	coref	23-35[196_186]
23-9	3986-3995	proximity	place[186]	new[186]	_	_
23-10	3996-3998	to	place[186]	new[186]	_	_
23-11	3999-4006	traffic	place[186]|abstract	new[186]|new	coref	23-38
23-12	4007-4008	,	_	_	_	_
23-13	4009-4014	their	person|abstract[189]	giv|giv[189]	ana|coref	23-30|25-5[217_189]
23-14	4015-4024	potential	abstract[189]	giv[189]	_	_
23-15	4025-4029	dose	abstract[189]	giv[189]	_	_
23-16	4030-4032	is	_	_	_	_
23-17	4033-4039	likely	_	_	_	_
23-18	4040-4042	to	_	_	_	_
23-19	4043-4045	be	_	_	_	_
23-20	4046-4052	higher	_	_	_	_
23-21	4053-4057	than	_	_	_	_
23-22	4058-4062	many	person[190]	giv[190]	_	_
23-23	4063-4068	other	person[190]	giv[190]	_	_
23-24	4069-4074	urban	person[190]	giv[190]	_	_
23-25	4075-4084	residents	person[190]	giv[190]	_	_
23-26	4085-4086	,	_	_	_	_
23-27	4087-4090	due	_	_	_	_
23-28	4091-4095	both	_	_	_	_
23-29	4096-4098	to	_	_	_	_
23-30	4099-4104	their	person|abstract[193]|abstract[194]	giv|giv[193]|giv[194]	coref|ana	23-30[194_193]|23-35
23-31	4105-4114	increased	abstract[193]|abstract[194]	giv[193]|giv[194]	_	_
23-32	4115-4126	respiration	abstract|abstract[193]|abstract[194]	giv|giv[193]|giv[194]	_	_
23-33	4127-4132	rates	abstract[193]|abstract[194]	giv[193]|giv[194]	_	_
23-34	4133-4136	and	abstract[194]	giv[194]	_	_
23-35	4137-4142	their	abstract[194]|person|place[196]	giv[194]|giv|giv[196]	coref	24-8
23-36	4143-4152	proximity	abstract[194]|place[196]	giv[194]|giv[196]	_	_
23-37	4153-4155	to	abstract[194]|place[196]	giv[194]|giv[196]	_	_
23-38	4156-4163	traffic	abstract[194]|place[196]|abstract|abstract[198]	giv[194]|giv[196]|giv|giv[198]	coref	28-16
23-39	4164-4171	sources	abstract[194]|place[196]|abstract[198]	giv[194]|giv[196]|giv[198]	_	_
23-40	4172-4173	.	_	_	_	_

#Text=For example , Zuurbier et al. estimated cyclists inhale twice as much ultra fine particle ( UFP counts ) and PM2.5 ( mass ) per unit time as car and bus occupants because of their much higher minute ventilation , even though the measured UFP and PM concentrations were higher inside the vehicles .
24-1	4174-4177	For	_	_	_	_
24-2	4178-4185	example	_	_	_	_
24-3	4186-4187	,	_	_	_	_
24-4	4188-4196	Zuurbier	person	new	_	_
24-5	4197-4199	et	_	_	_	_
24-6	4200-4203	al.	_	_	_	_
24-7	4204-4213	estimated	_	_	_	_
24-8	4214-4222	cyclists	person	giv	coref	25-10
24-9	4223-4229	inhale	_	_	_	_
24-10	4230-4235	twice	object[201]	new[201]	_	_
24-11	4236-4238	as	object[201]	new[201]	_	_
24-12	4239-4243	much	object[201]	new[201]	_	_
24-13	4244-4249	ultra	object[201]	new[201]	_	_
24-14	4250-4254	fine	object[201]	new[201]	_	_
24-15	4255-4263	particle	object[201]	new[201]	_	_
24-16	4264-4265	(	_	_	_	_
24-17	4266-4269	UFP	organization	new	coref	24-45
24-18	4270-4276	counts	_	_	_	_
24-19	4277-4278	)	_	_	_	_
24-20	4279-4282	and	_	_	_	_
24-21	4283-4288	PM2.5	abstract	new	appos	24-23
24-22	4289-4290	(	_	_	_	_
24-23	4291-4295	mass	abstract	giv	coref	27-34
24-24	4296-4297	)	_	_	_	_
24-25	4298-4301	per	_	_	_	_
24-26	4302-4306	unit	time[205]	new[205]	_	_
24-27	4307-4311	time	time[205]	new[205]	_	_
24-28	4312-4314	as	_	_	_	_
24-29	4315-4318	car	object|object[207]|person[209]	new|new[207]|new[209]	ana|coref	24-35[0_209]|24-52[215_207]
24-30	4319-4322	and	object[207]|person[209]	new[207]|new[209]	_	_
24-31	4323-4326	bus	object[207]|object|person[209]	new[207]|new|new[209]	_	_
24-32	4327-4336	occupants	person[209]	new[209]	_	_
24-33	4337-4344	because	_	_	_	_
24-34	4345-4347	of	_	_	_	_
24-35	4348-4353	their	person|abstract[212]	giv|new[212]	coref	26-9[222_212]
24-36	4354-4358	much	abstract[212]	new[212]	_	_
24-37	4359-4365	higher	abstract[212]	new[212]	_	_
24-38	4366-4372	minute	time|abstract[212]	new|new[212]	_	_
24-39	4373-4384	ventilation	abstract[212]	new[212]	_	_
24-40	4385-4386	,	_	_	_	_
24-41	4387-4391	even	_	_	_	_
24-42	4392-4398	though	_	_	_	_
24-43	4399-4402	the	abstract[214]	giv[214]	_	_
24-44	4403-4411	measured	abstract[214]	giv[214]	_	_
24-45	4412-4415	UFP	organization|abstract[214]	giv|giv[214]	_	_
24-46	4416-4419	and	abstract[214]	giv[214]	_	_
24-47	4420-4422	PM	abstract[214]	giv[214]	_	_
24-48	4423-4437	concentrations	abstract[214]	giv[214]	_	_
24-49	4438-4442	were	_	_	_	_
24-50	4443-4449	higher	_	_	_	_
24-51	4450-4456	inside	_	_	_	_
24-52	4457-4460	the	object[215]	giv[215]	_	_
24-53	4461-4469	vehicles	object[215]	giv[215]	_	_
24-54	4470-4471	.	_	_	_	_

#Text=A similar study found the average daily dose of cyclists was 1.06 – 1.30 times higher than non-cyclists .
25-1	4472-4473	A	abstract[216]	giv[216]	_	_
25-2	4474-4481	similar	abstract[216]	giv[216]	_	_
25-3	4482-4487	study	abstract[216]	giv[216]	_	_
25-4	4488-4493	found	_	_	_	_
25-5	4494-4497	the	abstract[217]	giv[217]	coref	26-1[221_217]
25-6	4498-4505	average	abstract[217]	giv[217]	_	_
25-7	4506-4511	daily	abstract[217]	giv[217]	_	_
25-8	4512-4516	dose	abstract[217]	giv[217]	_	_
25-9	4517-4519	of	abstract[217]	giv[217]	_	_
25-10	4520-4528	cyclists	abstract[217]|person	giv[217]|giv	coref	26-14
25-11	4529-4532	was	_	_	_	_
25-12	4533-4537	1.06	time[219]	new[219]	_	_
25-13	4538-4539	–	time[219]	new[219]	_	_
25-14	4540-4544	1.30	time[219]	new[219]	_	_
25-15	4545-4550	times	time[219]	new[219]	_	_
25-16	4551-4557	higher	_	_	_	_
25-17	4558-4562	than	_	_	_	_
25-18	4563-4575	non-cyclists	person	new	_	_
25-19	4576-4577	.	_	_	_	_

#Text=This larger inhaled dose is likely due to the average minute ventilation of cyclists being 4.3 times higher than vehicle passengers .
26-1	4578-4582	This	abstract[221]	giv[221]	ana	31-2[0_221]
26-2	4583-4589	larger	abstract[221]	giv[221]	_	_
26-3	4590-4597	inhaled	abstract[221]	giv[221]	_	_
26-4	4598-4602	dose	abstract[221]	giv[221]	_	_
26-5	4603-4605	is	_	_	_	_
26-6	4606-4612	likely	_	_	_	_
26-7	4613-4616	due	_	_	_	_
26-8	4617-4619	to	_	_	_	_
26-9	4620-4623	the	abstract[222]	giv[222]	_	_
26-10	4624-4631	average	abstract[222]	giv[222]	_	_
26-11	4632-4638	minute	abstract[222]	giv[222]	_	_
26-12	4639-4650	ventilation	abstract[222]	giv[222]	_	_
26-13	4651-4653	of	abstract[222]	giv[222]	_	_
26-14	4654-4662	cyclists	abstract[222]|person	giv[222]|giv	coref	28-8
26-15	4663-4668	being	_	_	_	_
26-16	4669-4672	4.3	time[224]	new[224]	_	_
26-17	4673-4678	times	time[224]	new[224]	_	_
26-18	4679-4685	higher	_	_	_	_
26-19	4686-4690	than	_	_	_	_
26-20	4691-4698	vehicle	object|person[226]	new|new[226]	_	_
26-21	4699-4709	passengers	person[226]	new[226]	_	_
26-22	4710-4711	.	_	_	_	_

#Text=In terms of potential exposures , recent studies in major North American cities have found average exposures along bike routes to be higher than comparable fixed sidewalk stations and significant associations between higher PM2.5 emissions and bicycling volume .
27-1	4712-4714	In	_	_	_	_
27-2	4715-4720	terms	_	_	_	_
27-3	4721-4723	of	_	_	_	_
27-4	4724-4733	potential	abstract[227]	giv[227]	coref	27-16[231_227]
27-5	4734-4743	exposures	abstract[227]	giv[227]	_	_
27-6	4744-4745	,	_	_	_	_
27-7	4746-4752	recent	abstract[228]	giv[228]	_	_
27-8	4753-4760	studies	abstract[228]	giv[228]	_	_
27-9	4761-4763	in	abstract[228]	giv[228]	_	_
27-10	4764-4769	major	abstract[228]|place[230]	giv[228]|new[230]	coref	29-15[260_230]
27-11	4770-4775	North	abstract[228]|person|place[230]	giv[228]|new|new[230]	_	_
27-12	4776-4784	American	abstract[228]|place[230]	giv[228]|new[230]	_	_
27-13	4785-4791	cities	abstract[228]|place[230]	giv[228]|new[230]	_	_
27-14	4792-4796	have	_	_	_	_
27-15	4797-4802	found	_	_	_	_
27-16	4803-4810	average	abstract[231]|abstract[232]	giv[231]|giv[232]	coref	27-16[232_231]
27-17	4811-4820	exposures	abstract[231]|abstract[232]	giv[231]|giv[232]	_	_
27-18	4821-4826	along	abstract[231]|abstract[232]	giv[231]|giv[232]	_	_
27-19	4827-4831	bike	abstract[231]|abstract[232]|object|place[234]	giv[231]|giv[232]|new|new[234]	_	_
27-20	4832-4838	routes	abstract[231]|abstract[232]|place[234]	giv[231]|giv[232]|new[234]	_	_
27-21	4839-4841	to	abstract[232]	giv[232]	_	_
27-22	4842-4844	be	abstract[232]	giv[232]	_	_
27-23	4845-4851	higher	abstract[232]	giv[232]	_	_
27-24	4852-4856	than	abstract[232]	giv[232]	_	_
27-25	4857-4867	comparable	abstract[232]|place[236]	giv[232]|new[236]	_	_
27-26	4868-4873	fixed	abstract[232]|place[236]	giv[232]|new[236]	_	_
27-27	4874-4882	sidewalk	abstract[232]|place|place[236]	giv[232]|new|new[236]	_	_
27-28	4883-4891	stations	abstract[232]|place[236]	giv[232]|new[236]	_	_
27-29	4892-4895	and	abstract[232]	giv[232]	_	_
27-30	4896-4907	significant	abstract[232]|abstract[237]	giv[232]|new[237]	_	_
27-31	4908-4920	associations	abstract[232]|abstract[237]	giv[232]|new[237]	_	_
27-32	4921-4928	between	abstract[232]|abstract[237]	giv[232]|new[237]	_	_
27-33	4929-4935	higher	abstract[232]|abstract[237]|abstract[239]	giv[232]|new[237]|new[239]	_	_
27-34	4936-4941	PM2.5	abstract[232]|abstract[237]|abstract|abstract[239]	giv[232]|new[237]|giv|new[239]	_	_
27-35	4942-4951	emissions	abstract[232]|abstract[237]|abstract[239]	giv[232]|new[237]|new[239]	_	_
27-36	4952-4955	and	abstract[232]|abstract[237]	giv[232]|new[237]	_	_
27-37	4956-4965	bicycling	abstract[232]|abstract[237]|organization|abstract[241]	giv[232]|new[237]|giv|new[241]	_	_
27-38	4966-4972	volume	abstract[232]|abstract[237]|abstract[241]	giv[232]|new[237]|new[241]	_	_
27-39	4973-4974	.	_	_	_	_

#Text=Pedestrians and joggers , in addition to cyclists , receive higher potential inhaled doses of traffic related pollutants , but cyclists are the preferred cohort because the exposure and health assessment equipment is less burdensome for cyclists to carry .
28-1	4975-4986	Pedestrians	person	new	_	_
28-2	4987-4990	and	_	_	_	_
28-3	4991-4998	joggers	person	new	_	_
28-4	4999-5000	,	_	_	_	_
28-5	5001-5003	in	_	_	_	_
28-6	5004-5012	addition	_	_	_	_
28-7	5013-5015	to	_	_	_	_
28-8	5016-5024	cyclists	person	giv	coref	28-21
28-9	5025-5026	,	_	_	_	_
28-10	5027-5034	receive	_	_	_	_
28-11	5035-5041	higher	substance[245]	new[245]	_	_
28-12	5042-5051	potential	substance[245]	new[245]	_	_
28-13	5052-5059	inhaled	substance[245]	new[245]	_	_
28-14	5060-5065	doses	substance[245]	new[245]	_	_
28-15	5066-5068	of	substance[245]	new[245]	_	_
28-16	5069-5076	traffic	substance[245]|abstract|substance[247]	new[245]|giv|new[247]	_	_
28-17	5077-5084	related	substance[245]|substance[247]	new[245]|new[247]	_	_
28-18	5085-5095	pollutants	substance[245]|substance[247]	new[245]|new[247]	_	_
28-19	5096-5097	,	_	_	_	_
28-20	5098-5101	but	_	_	_	_
28-21	5102-5110	cyclists	person	giv	coref	28-23[249_0]
28-22	5111-5114	are	_	_	_	_
28-23	5115-5118	the	person[249]	giv[249]	coref	28-37[0_249]
28-24	5119-5128	preferred	person[249]	giv[249]	_	_
28-25	5129-5135	cohort	person[249]	giv[249]	_	_
28-26	5136-5143	because	_	_	_	_
28-27	5144-5147	the	object[253]	new[253]	_	_
28-28	5148-5156	exposure	abstract|object[253]	giv|new[253]	coref	29-20[262_0]
28-29	5157-5160	and	object[253]	new[253]	_	_
28-30	5161-5167	health	abstract|abstract[252]|object[253]	giv|giv[252]|new[253]	coref	30-8[268_0]
28-31	5168-5178	assessment	abstract[252]|object[253]	giv[252]|new[253]	_	_
28-32	5179-5188	equipment	object[253]	new[253]	_	_
28-33	5189-5191	is	_	_	_	_
28-34	5192-5196	less	_	_	_	_
28-35	5197-5207	burdensome	_	_	_	_
28-36	5208-5211	for	_	_	_	_
28-37	5212-5220	cyclists	person	giv	_	_
28-38	5221-5223	to	_	_	_	_
28-39	5224-5229	carry	_	_	_	_
28-40	5230-5231	.	_	_	_	_

#Text=Lastly , given the growth in ridership and infrastructural support for urban cycling in many U.S. cities , understanding cyclist exposure patterns can help address many practical issues of concern to the public .
29-1	5232-5238	Lastly	_	_	_	_
29-2	5239-5240	,	_	_	_	_
29-3	5241-5246	given	_	_	_	_
29-4	5247-5250	the	abstract[255]	new[255]	_	_
29-5	5251-5257	growth	abstract[255]	new[255]	_	_
29-6	5258-5260	in	abstract[255]	new[255]	_	_
29-7	5261-5270	ridership	abstract[255]|person	new[255]|new	_	_
29-8	5271-5274	and	abstract[255]	new[255]	_	_
29-9	5275-5290	infrastructural	abstract[255]|abstract[257]	new[255]|new[257]	_	_
29-10	5291-5298	support	abstract[255]|abstract[257]	new[255]|new[257]	_	_
29-11	5299-5302	for	abstract[255]|abstract[257]	new[255]|new[257]	_	_
29-12	5303-5308	urban	abstract[255]|abstract[257]|abstract[258]	new[255]|new[257]|new[258]	_	_
29-13	5309-5316	cycling	abstract[255]|abstract[257]|abstract[258]	new[255]|new[257]|new[258]	_	_
29-14	5317-5319	in	abstract[255]|abstract[257]	new[255]|new[257]	_	_
29-15	5320-5324	many	abstract[255]|abstract[257]|place[260]	new[255]|new[257]|giv[260]	_	_
29-16	5325-5329	U.S.	abstract[255]|abstract[257]|place|place[260]	new[255]|new[257]|new|giv[260]	_	_
29-17	5330-5336	cities	abstract[255]|abstract[257]|place[260]	new[255]|new[257]|giv[260]	_	_
29-18	5337-5338	,	_	_	_	_
29-19	5339-5352	understanding	_	_	_	_
29-20	5353-5360	cyclist	person|abstract[262]|abstract[263]	new|giv[262]|giv[263]	_	_
29-21	5361-5369	exposure	abstract[262]|abstract[263]	giv[262]|giv[263]	_	_
29-22	5370-5378	patterns	abstract[263]	giv[263]	_	_
29-23	5379-5382	can	_	_	_	_
29-24	5383-5387	help	_	_	_	_
29-25	5388-5395	address	_	_	_	_
29-26	5396-5400	many	abstract[264]	new[264]	_	_
29-27	5401-5410	practical	abstract[264]	new[264]	_	_
29-28	5411-5417	issues	abstract[264]	new[264]	_	_
29-29	5418-5420	of	abstract[264]	new[264]	_	_
29-30	5421-5428	concern	abstract[264]|abstract[265]	new[264]|new[265]	_	_
29-31	5429-5431	to	abstract[264]|abstract[265]	new[264]|new[265]	_	_
29-32	5432-5435	the	abstract[264]|abstract[265]|person[266]	new[264]|new[265]|new[266]	_	_
29-33	5436-5442	public	abstract[264]|abstract[265]|person[266]	new[264]|new[265]|new[266]	_	_
29-34	5443-5444	.	_	_	_	_

#Text=Does biking to and from work affect cardiovascular health or indicators of future health outcomes ?
30-1	5445-5449	Does	_	_	_	_
30-2	5450-5456	biking	_	_	_	_
30-3	5457-5459	to	_	_	_	_
30-4	5460-5463	and	_	_	_	_
30-5	5464-5468	from	_	_	_	_
30-6	5469-5473	work	abstract	new	_	_
30-7	5474-5480	affect	_	_	_	_
30-8	5481-5495	cardiovascular	abstract[268]	giv[268]	coref	30-14[0_268]
30-9	5496-5502	health	abstract[268]	giv[268]	_	_
30-10	5503-5505	or	_	_	_	_
30-11	5506-5516	indicators	abstract[269]	new[269]	_	_
30-12	5517-5519	of	abstract[269]	new[269]	_	_
30-13	5520-5526	future	abstract[269]|abstract[271]	new[269]|giv[271]	_	_
30-14	5527-5533	health	abstract[269]|abstract|abstract[271]	new[269]|giv|giv[271]	coref	32-3
30-15	5534-5542	outcomes	abstract[269]|abstract[271]	new[269]|giv[271]	_	_
30-16	5543-5544	?	_	_	_	_

#Text=Should one limit exercise and biking to the less polluted days or less polluted areas of the city ?
31-1	5545-5551	Should	_	_	_	_
31-2	5552-5555	one	abstract	giv	_	_
31-3	5556-5561	limit	_	_	_	_
31-4	5562-5570	exercise	event	giv	_	_
31-5	5571-5574	and	_	_	_	_
31-6	5575-5581	biking	object	new	_	_
31-7	5582-5584	to	_	_	_	_
31-8	5585-5588	the	time[275]	new[275]	_	_
31-9	5589-5593	less	time[275]	new[275]	_	_
31-10	5594-5602	polluted	time[275]	new[275]	_	_
31-11	5603-5607	days	time[275]	new[275]	_	_
31-12	5608-5610	or	_	_	_	_
31-13	5611-5615	less	place[276]	new[276]	_	_
31-14	5616-5624	polluted	place[276]	new[276]	_	_
31-15	5625-5630	areas	place[276]	new[276]	_	_
31-16	5631-5633	of	place[276]	new[276]	_	_
31-17	5634-5637	the	place[276]|place[277]	new[276]|new[277]	_	_
31-18	5638-5642	city	place[276]|place[277]	new[276]|new[277]	_	_
31-19	5643-5644	?	_	_	_	_

#Text=Do the health benefits of commuting by bicycle outweigh the costs ?
32-1	5645-5647	Do	_	_	_	_
32-2	5648-5651	the	abstract[279]	new[279]	_	_
32-3	5652-5658	health	abstract|abstract[279]	giv|new[279]	_	_
32-4	5659-5667	benefits	abstract[279]	new[279]	_	_
32-5	5668-5670	of	abstract[279]	new[279]	_	_
32-6	5671-5680	commuting	abstract[279]	new[279]	_	_
32-7	5681-5683	by	abstract[279]	new[279]	_	_
32-8	5684-5691	bicycle	abstract[279]|object	new[279]|new	_	_
32-9	5692-5700	outweigh	_	_	_	_
32-10	5701-5704	the	abstract[281]	new[281]	_	_
32-11	5705-5710	costs	abstract[281]	new[281]	_	_
32-12	5711-5712	?	_	_	_	_
